GPP
Great Point Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Buy |
2,000,000
+188,004
| +10% | +$1.21M | 8.34% | 3 |
|
|
2025
Q1 | $6.41M | Buy |
+1,811,996
| New | +$6.41M | 3.4% | 12 |
|
|
2023
Q3 | – | Sell |
-968,795
| Closed | -$20.9M | – | 40 |
|
|
2023
Q2 | $20.9M | Buy |
968,795
+185,000
| +24% | +$3.99M | 4.09% | 8 |
|
|
2023
Q1 | $23M | Buy |
783,795
+593,795
| +313% | +$17.4M | 4.52% | 8 |
|
|
2022
Q4 | $7.02M | Buy |
+190,000
| New | +$7.02M | 1.38% | 24 |
|